901 related articles for article (PubMed ID: 17363065)
21. [Levosimendan].
Michels G; Herzig S; Hoppe UC
Dtsch Med Wochenschr; 2005 Oct; 130(43):2444-6. PubMed ID: 16240243
[No Abstract] [Full Text] [Related]
22. Levosimendan: a review of its use in the management of acute decompensated heart failure.
Innes CA; Wagstaff AJ
Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085
[TBL] [Abstract][Full Text] [Related]
23. Newer inotropes in pediatric heart failure.
Hoffman TM
J Cardiovasc Pharmacol; 2011 Aug; 58(2):121-5. PubMed ID: 21386708
[TBL] [Abstract][Full Text] [Related]
24. The cardioprotective effects of levosimendan: preclinical and clinical evidence.
Pollesello P; Papp Z
J Cardiovasc Pharmacol; 2007 Sep; 50(3):257-63. PubMed ID: 17878752
[TBL] [Abstract][Full Text] [Related]
25. Levosimendan: a new dual-action drug in the treatment of acute heart failure.
Mebazaa A; Erhardt L
Int J Clin Pract; 2003 Jun; 57(5):410-6. PubMed ID: 12846347
[TBL] [Abstract][Full Text] [Related]
26. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.
Flevari P; Parissis JT; Leftheriotis D; Panou F; Kourea K; Kremastinos DT
Am J Cardiol; 2006 Dec; 98(12):1641-5. PubMed ID: 17145226
[TBL] [Abstract][Full Text] [Related]
27. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
[TBL] [Abstract][Full Text] [Related]
28. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
Nieminen MS; Sandell EP
Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
[TBL] [Abstract][Full Text] [Related]
29. Role of levosimendan in sepsis and septic shock.
Pinto BB; Rehberg S; Ertmer C; Westphal M
Curr Opin Anaesthesiol; 2008 Apr; 21(2):168-77. PubMed ID: 18443483
[TBL] [Abstract][Full Text] [Related]
30. Levosimendan, a new inotropic and vasodilator agent.
Toller WG; Stranz C
Anesthesiology; 2006 Mar; 104(3):556-69. PubMed ID: 16508404
[TBL] [Abstract][Full Text] [Related]
31. Is calcium sensitization the best strategy to improve myocardial contractility in acute heart failure?
Erhardt LR
Ital Heart J; 2003 May; 4 Suppl 2():27S-33S. PubMed ID: 14635367
[TBL] [Abstract][Full Text] [Related]
32. Levosimendan: from basic science to clinical practice.
Parissis JT; Rafouli-Stergiou P; Paraskevaidis I; Mebazaa A
Heart Fail Rev; 2009 Dec; 14(4):265-75. PubMed ID: 19101796
[TBL] [Abstract][Full Text] [Related]
33. Effects of levosimendan on the energy balance: preclinical and clinical evidence.
Nieminen MS; Pollesello P; Vajda G; Papp Z
J Cardiovasc Pharmacol; 2009 Apr; 53(4):302-10. PubMed ID: 19276987
[TBL] [Abstract][Full Text] [Related]
34. Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals.
Sundberg S; Antila S; Scheinin H; Häyhä M; Virtanen M; Lehtonen L
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):629-35. PubMed ID: 9876999
[TBL] [Abstract][Full Text] [Related]
35. Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity.
Graudins A; Najafi J; Rur-SC MP
Clin Toxicol (Phila); 2008 Jan; 46(1):50-6. PubMed ID: 17926153
[TBL] [Abstract][Full Text] [Related]
36. Levosimendan compared with dobutamine in low output patients.
Nieminen MS
Minerva Anestesiol; 2003 Apr; 69(4):258-63. PubMed ID: 12766717
[TBL] [Abstract][Full Text] [Related]
37. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
Duygu H; Ozerkan F; Zoghi M; Nalbantgil S; Yildiz A; Akilli A; Akin M; Nazli C; Ergene O
Int J Clin Pract; 2008 Feb; 62(2):228-33. PubMed ID: 17949428
[TBL] [Abstract][Full Text] [Related]
38. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
Cavana M; Pignataro C; Fraticelli A; Mebazaa A
Ital Heart J; 2003 May; 4 Suppl 2():61S-64S. PubMed ID: 14635372
[TBL] [Abstract][Full Text] [Related]
39. Levosimendan.
Figgitt DP; Gillies PS; Goa KL
Drugs; 2001; 61(5):613-27; discussion 628-9. PubMed ID: 11368286
[TBL] [Abstract][Full Text] [Related]
40. Evidence-based use of levosimendan in different clinical settings.
De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M
Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
